Centessa Pharmaceuticals Reaches Analyst Target Price
February 15, 2024 at 07:56 AM EST
In recent trading, shares of Centessa Pharmaceuticals PLC (CNTA) have crossed above the average analyst 12-month target price of $10.00, changing hands for $10.18/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuation, or, re-adjust their target price to a higher level..